Company Overview
ACI Limited is a leading manufacturer of pharmaceutical finished formulations and modified release ready to fill bulk pellets in Bangladesh. ACI manufactures a wide range of dosage forms including tablet, capsule, dry syrup, powder, cream, ointment, ophthalmic preparations, Metered Dose Inhalers (MDI) and small volume parenterals in several world-class manufacturing plants. ACI also manufactures ready- tofill bulk pellets of anti-inflammatory, antiulcerant, cardiovascular, respiratory and neutraceuticals. ACI was transformed from ICI Plc, a UK based multinational company in 1992 when ICI Plc sold its stakes and was renamed as Advanced Chemical Industries Ltd. The multinational heritage of ICI is embodied in the culture of ACI. ACI Limited is a public limited company having stocks traded in all the bourses of Bangladesh. Since its inception in 1992, ACI has earned the image of a quality house of pharmaceuticals and achieved impressive growth. Quality affordable products manufactured in world class manufacturing plants, diversified product portfolio, fast new product development capability, own R & D facilities to develop both formulations and ready to fill bulk pellets, innovative and market focused marketing, professional management and experience in international markets are drivers of ACI's growth. Today ACI is the fastest growing major pharmaceutical company in Bangladesh. ACI's business today is diverse in its product line and the breadth of its market participation. ACI has 224 products in 481 dosage forms covering almost all the therapeutic areas. This diversification will ensure that ACI will maintain its track record of strong growth and stability.
ACI is the first company in Bangladesh to obtain certification